Background: The significance of cardiac troponin I (cTnI) elevation after trauma is debated. We therefore explored the association between cTnI elevation at admission after trauma and ICU mortality. Methods: We performed a retrospective analysis from a prospectively constituted database, of patients admitted to ICU after trauma at a single centre, over a 36 month period. According to cTnI plasma concentration at admission, patients were categorised into three groups: normal (<0.05 ng ml À1 ), intermediate (0.05e0.99 ng ml
Editor's key points
Cardiac troponin elevation is often used to indicate myocardial contusion after trauma, but other causes are likely to co-exist. In a retrospective cohort study, troponin elevation had a concentration-dependent association with ICU mortality after trauma. Troponin elevation was also associated with chest trauma, shock, and hypoxaemia. Troponin estimation can be used to aid early risk stratification in trauma.
Plasma release of cardiac troponin I (cTnI) is common in the early phase of severe trauma. Its incidence can be as high as 70% in isolated blunt chest trauma, 1e4 whereas its incidence in severe trauma is estimated to be around 20%. 5e8 Its release follows disruption of myocardial cell membranes, signifying specific myocardial injury. In the trauma setting cTnI elevation is a surrogate of myocardial contusion. 9 Clinicians measure myocardial enzymes as a diagnostic biomarker of myocardial contusion and attributed myocardial contusion in mechanical chest trauma. However, the lower than expected incidence of contusion in autopsy series 10, 11 and the disparity with the incidence of observed troponin elevation in blunt chest trauma, made this association questionable. The lack of a gold standard to diagnose myocardial contusion complicates the picture further. Moreover, cTnI elevation has been described even in the absence of chest trauma. 12, 13 Put together these observations suggest poor specificity of the cTnI in the diagnosis of myocardial contusion. 14, 15 Other causes of cTnI elevation after trauma include arterial hypotension, 16 traumatic brain injury, 17e20 or hypoxaemia, 21 but others have been described. 22e24 We therefore question the role of chest trauma per se as the main cause of cTnI release in non-selected blunt chest trauma. Moreover in the past decade the association between mortality and cTnI plasma elevations has been observed in various conditions such as myocardial infarction, 25 chronic heart failure, atrial fibrillation, 26 renal insufficiency, 27 sepsis, 28 or even in non-cardiac surgical patients. 29 In trauma, although often performed early on admission, the contribution of a systematic cTnI plasma level assessment after major trauma to clinical routine remains unclear and its capacity to predict survival is still debated. 7, 8, 20, 30, 31 Some studies concentrated only on selected brain trauma patients, 20, 31 and prognostic analyses were always performed among the cTnI plasma concentrations during a 24e48 h period after admission. 7, 8, 20, 31 These late samples could not provide early prognostic stratification. To the extent that most of the deaths occur in the first 48 h, we need to explore the prognostic value of the very early release of cTnI after severe trauma. The first objective of our study was to assess the association between ICU mortality and cTnI release at admission, at the earliest moment possible after severe trauma. Our secondary objectives were to assess the association between cTnI release and Day 2 mortality (within 48 h after admission) and to identify pre-hospital and clinical factors associated with this increase.
Methods

Study design and settings
This was a retrospective study from a prospective, multicentre, regional scientific database, the TraumaBase © (www.
traumabase.eu). At the time of the study three regional level I trauma centres contributed patients to the database (Beaujon University Hospital, Kremlin-Bicêtre University Hospital, and Piti e-Salpêtri ere University Hospital). For this study, only patients from the Beaujon centre were screened and included. 
Selection of patients
All consecutive trauma patients triaged according to French out-of-hospital trauma algorithm, 32 and admitted to the Beaujon trauma centre between January 2011 and December 2013, were screened for inclusion. Only patients for whom a troponin assay was performed at the time of hospital admission were included in the analysis. In cases of several cTnI assessments, only the first cTnI value was retained for analysis. Patients for whom first cTnI assessment was performed after any surgical intervention were excluded. The plasma concentration of cTnI was measured using immunological methods of chemiluminescence in nanograms per millilitre (STAT ARCHITECT Troponin-I ® ; Abbott Laboratories, IL, North Chicago, 60064, USA; fifth-generation troponin assay). We defined an elevated cTnI as an abnormal cTnI plasma concentration !0.05 ng ml À1 corresponding to the detection threshold. This value corresponds also to the 99th percentile for our laboratory during the study period. According to cTnI plasma concentration, patients were categorised into three groups: patients with normal level (<0.05 ng ml
À1
), intermediate level (0.05e0.99 ng ml À1 ), and high level (!1.0 ng ml À1 ). We used this classification in preference to using the cTnI median value 20 considering a cTnI value !1.0 ng ml À1 as a significant threshold for the diagnosis of myocardial necrosis.
15,30
Patient management and data collection
For each patient, the following initial clinical variables were recorded by emergency medical service (EMS): lowest out-ofhospital systolic and diastolic arterial pressure, highest outof-hospital heart rate, lowest out-of-hospital peripheral oxygen saturation (SpO 2 ) and Glasgow Coma Scale (GCS) score, presence or absence of unequal pupils, cardiorespiratory arrest, shock, and the need for vasopressors. We also recorded age, gender, ASA physical status score, BMI, presence of antiplatelet treatment on admission, mechanism of injury, estimated energy transfer (low vs high), total pre-hospital time, haemodynamic stability as estimated by EMS providers (unstable or not unstable), and laboratory parameters at admission, including cTnI, lactate, bicarbonate, and haemoglobin blood levels. All patients received a standardised management protocol used in routine in the unit including complete medical examination more or less coupled with the Focused Assessment with Sonography for Trauma, and whole-body computed tomography scan. After this first evaluation, severity on admission was assessed with the Simplified Acute Physiology Score (SAPS) II. 33 Trauma injury assessment was performed with calculation of Injury Severity Score (ISS) score. 34 Resuscitation measures in the trauma bay and critical care unit (mechanical ventilation and use of vasopressors) were also reported.
Outcome measures
Follow-up was conducted for all patients until ICU discharge, regardless of their vital status. We recorded the Day 2 mortality, defined as a death occurring within 48 h after ICU admission, and ICU mortality defined by death at ICU discharge.
Definitions
Severe tachycardia was defined with a maximum HR of !120 beats min À1 , shock by a minimum systolic blood pressure of 90 mm Hg, and hypoxaemia defined by an SpO 2 <90%, Mechanisms of trauma were classified into four categories: 1) penetrating trauma, 2) road traffic accidents, 3) falls, and 4) others. The severity of each anatomical lesion was assessed by the corresponding Abbreviated Injury Score (AIS, version 2008). Thoracic and abdominal traumas were classified as minor (AIS 1 and 2) and severe trauma (AIS ! 3). Brain injury was classified as minor (GCS 13e15), moderate (GCS 9e12), and severe (GCS 3e8) in the presence of anatomical lesions confirmed by computed tomography imaging. 35 
Statistical analysis
We estimated the sample size based on the need to have at least 10 patients for each outcome to be reliably included in a stable logistic model. 36 In the database of approximately 1000 patients, and assuming a prevalence of death in ICU of 10%, we planned to identify up to 10 factors that could be associated with ICU mortality. Continuous variables are reported using median and interquartile range, and categorical variables using number of observations and percentages. The prevalence of patients with elevated cTnI is reported with its 95% confidence interval (95% CI). Factors associated with ICU mortality were explored in univariate analysis using Student's t-test or Wilcoxon or KruskaleWallis test for continuous variables, and c
test or
Fisher's exact test for categorical variables, as appropriate. Factors associated with ICU mortality in univariate analysis (P<0.20), or clinically relevant ones, were entered in a multivariate logistic regression. In case of colinearity between variables (such as thoracic trauma and thoracic AIS, systolic BP and diastolic BP, or AIS and ISS), we selected the more clinically relevant. The SAPS II was not included in the models because it summarised many other variables included and increased the risk of collinearity between variables. The final selection was performed using the stepwise selection based on the Akaike criterion. Sensitivity analysis was performed by running a new model including ISS in place of individual AIS factors.
Furthermore, the association of cTnI levels (categories) with Day 2 mortality and the identification of factors associated with cTnI elevation were assessed in the same way, using univariate and multivariate logistic regression models. Results of multivariate analysis are reported with adjusted odds ratios (OR) and their 95% CI. Analyses were performed using R Statistical Software Version 3.1.3 (The R Foundation for Statistical Computing, GNU General Public Licence, MA, Boston, 02111, USA). Figure 1 describes the patient flow in the study. A total of 994 patients were included. The characteristics of the included population are described in Table 1. Table 2 reports some comparison by degrees of cTnI levels. Supplementary Table S1 describes the characteristics of the overall population including patients without cTnI assay performed at admission and excluding patients with missing data.
Results
Analysis of ICU mortality
A total of 114 (11%) patients died during their ICU stay. Factors associated with the ICU mortality are reported in Table S2 (univariate analysis) and Figure S1 reports the cumulative incidence of ICU death by cTnI levels. Sensitivity analysis replacing the AIS by the ISS showed consistent results (Table S3 ).
Analysis of Day 2 mortality
Among the 114 patients who died in the ICU, 75 (66%) died within 48 h after admission. Factors associated with Day 2 mortality are reported in Table S4 (univariate analysis) and Table 4 (multivariate analysis). As reported in this table, cTnI elevation was identified as an independent factor associated with Day 2 mortality with a concentrationeresponse relationship. Sensitivity analysis replacing the AIS by the ISS showed consistent results (Table S5) .
Analysis of cTnI elevation
Troponin I release was observed in 177 (18%) patients. Among them, the median value of cTnI was 0.25 (0.12e0.86) ng ml À1 and exceeded 1 ng ml À1 in 38 (21%) patients. Factors associated with the cTnI elevation are reported in Table S6 (univariate analysis) and 
Discussion
To our knowledge, this is the largest prospective cohort of severe trauma focusing on cTnI release impact on ICU mortality and the first one reporting extensive pre-hospital data which may contribute to its release. We found that in severe trauma, cTnI plasma levels were elevated on admission to ICI in 18% of patients; this was associated with ICU and Day 2 mortality with a concentration-dependent effect, commonly co-existed with chest trauma and its severity, and was also associated with other initial conditions that express the overall severity such as shock or hypoxaemia. The incidence of cTnI elevation in our study was slightly lower than that reported in large recent trauma series. 3, 7, 15, 20, 31 This could be explained by the fact that these studies included a significant number of selected brain or chest trauma patients, and all of these studies focused on the increase of cTnI plasma levels over an 8e48 h period after admission. However, various in-hospital conditions, such as emergent surgery in the first 48 h, may also trigger cTnI release. 29 In the present study we sought to evaluate the capacity of very early cTnI plasma level to predict ICU mortality soon after admission and not after 24e48 h, as established prediction rules such as the SAPS II do. This is why we chose to study only the cTnI assay performed at admission and restricted the analysis of relationship between outcomes and out-of-hospital predictors. Elevated cTnI is a well-known independent predictor of morbidity and mortality in various non-traumatic conditions. In trauma, cTnI has previously been demonstrated as a strong predictor of mortality in brain injury. 20, 31 In multiple trauma, cTnI elevation is known to be strongly associated with cardiac complications such as arrhythmias or left ventricular dysfunction. 13, 30 However until recently, only two prospective studies with conflicting results analysed the association between cTnI release and mortality after major trauma. 7, 8 One study found a link between cTnI and in-hospital mortality. 8 In contrast, the results presented here illustrate for the first time an association between cTnI release measured on admission and Day 2 and ICU mortality after adjustment for several confounding factors. These results may be useful for daily practice. Indeed, despite the misunderstanding of the mechanism of cTnI release, its early measurement at admission may help physicians to identify early risk of death stratification, easier and faster than scores, which are often available after 24 h. This early cTnI assay may also serve as risk stratification in studies and would probably be more objective than scores, as many scores have subjective elements. For many years, myocardial enzyme release after trauma had been commonly related to direct mechanical chest trauma responsible for myocardial contusion. Informed by animal models, most studies evaluating troponin levels in trauma patients have only included patients with chest trauma and suspected myocardial contusion. However, in the absence of a 'well-accepted gold standard' for the diagnosis of myocardial contusion and without autopsy series including a cTnI assessment, the responsibility of a direct mechanical transmission of energy through the chest wall to cause myocardial damage and subsequent cTnI elevation has not been convincingly demonstrated in humans. Conversely, cTnI elevation is common without signs of mechanical chest trauma or myocardial contusion. As a consequence, in a large series of cTnI assays among 1081 severe trauma patients, serum cTnI release after trauma was more strongly related to the degree of overall injury and physiologic stress than to mechanical chest trauma. 8 In contrast, in addition to clinical surrogates of the trauma impact, our results demonstrated a strong association between the thoracic trauma severity and cTnI release. Prospective injury studies with a specific focus on the relationship between chest trauma and troponin level are rare, 5, 7, 8 but similar results could have been anticipated. Indeed, the literature exhibits a higher incidence of cTnI release in selected blunt chest trauma 3, 14 than that reported in non-selected severe trauma. 7 In addition, in a study including 728 consecutive multiple severe trauma of which 12% had a positive cTnI during the first 48 h, the presence of a chest trauma was significantly more frequent in patients with sustained and significant release of cTnI. 7 So these reports and our results support the strong association of a chest trauma in the mechanical myocardial injury and cTnI elevation even in nonselected chest trauma patients and even if the mechanisms of myocardial injury could not be formally explained. The present study has several limitations. First, the study was of retrospective design, which involves potential bias in patient selection or data collection. However, data were extracted from a prospectively managed database, which increases the reliability of the data collection. Second, we did not record information concerning the onset of arrhythmias or ventricular dysfunction, and neither did we obtain information on the causes of ICU death. Indeed, insofar as cTnI levels correlated with mortality, it would have been interesting to demonstrate whether the death was related to cardiovascular or other complications. Unfortunately, we did not analyse the electrocardiogram or include systematic echocardiography in our patients with cTnI elevation. Consequently, we were not able to describe the incidence of wall motion abnormalities associated with the increase of plasma levels of cTnI that would support a diagnosis of myocardial contusion. Third, regarding the low proportion of penetrating trauma, the results of our study may not be applicable for this specific population. Finally, although the mechanism of trauma was listed as a significant association with mortality, all estimates included unity and any conclusions on the prognostic value of this variable should be treated with caution.
To conclude, our results confirmed that cTnI release is frequent even in non-selected brain or blunt chest trauma. They highlight the strong role of the chest trauma in its elevation and could bring a new reliable and simple plasmatic biomarker for an immediate and objective stratification of the risk of death along the ICU stay. In light of these results, similar performance of high-sensitive troponin should be analysed. 
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